Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™ by Dave Giles | Mar 1, 2024 | News
Open Society Supports an Innovative Model to Make Naloxone Easier to Access Amidst the U.S. Overdose Crisis by Dave Giles | Dec 12, 2023 | News
Partnership to Save Lives: Harm Reduction Therapeutics to donate 200,000 RiVive™ naloxone doses to Remedy Alliance for free distribution by Dave Giles | Aug 17, 2023 | News
FDA APPROVAL OF RiVIVE™ IS A CRITICAL MILESTONE IN MAKING EMERGENCY TREATMENT OF OPIOID OVERDOSE MORE WIDELY AVAILABLE by Dave Giles | Aug 1, 2023 | News